- Home
- VFC vs XENE Comparison
VFC vs XENE Comparison
Compare VFC & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VFC | XENE |
|---|---|---|
| Founded | 1899 | 1996 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Apparel | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.0B | 5.7B |
| IPO Year | 1994 | 2014 |
Fundamental Metrics
Financial Performance| Metric | VFC | XENE |
|---|---|---|
| Price | $13.96 | $36.96 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 18 | 11 |
| Target Price | $18.24 | ★ $68.55 |
| AVG Volume (30 Days) | ★ 6.2M | 1.8M |
| Earning Date | 05-20-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 233.33 | N/A |
| EPS | ★ 0.64 | N/A |
| Revenue | ★ $10,488,556,000.00 | $311,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2.06 | $2,496.48 |
| P/E Ratio | $21.41 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $12.46 | $36.07 |
| 52 Week High | $22.27 | $72.66 |
Technical Indicators
Market Signals| Indicator | VFC | XENE |
|---|---|---|
| Relative Strength Index (RSI) | 55.09 | 16.82 |
| Support Level | $12.46 | N/A |
| Resistance Level | $15.32 | $45.39 |
| Average True Range (ATR) | 0.39 | 2.06 |
| MACD | 0.20 | -2.12 |
| Stochastic Oscillator | 96.75 | 3.50 |
Price Performance
Historical ComparisonAbout VFC V.F. Corporation
VF designs, produces, and distributes apparel, footwear, and accessories with a focus on active and outdoor brands. Its portfolio of 10 labels includes Vans, The North Face, Timberland, and Altra. VF markets its products in the Americas, Europe, and Asia-Pacific through wholesale sales to retailers, e-commerce, and company-owned and partner-owned branded stores. Tracing its roots to 1899, VF has evolved into its present form through many brand acquisitions and divestitures.
About XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.